Bien Bio
ActiveSummary
The computed 12-month bankruptcy probability of Bien Bio is 3.2% (moderate). The 2025 annual accounts show negative equity (-€88,160) and a net result of -€27,309. Equity is shrinking by about 20% per year across the filed financial years. Its solvency ranks better than 5% of 12,678 sector peers (NACE 47, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
14-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
29-10
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 90 days late
2024
27-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 27 days late
2023
04-09
Gazette deed
Permanent representatives: Peter Dossche and Isabel DecrockRegistered-office move6 facts ▸
Gazette deed
Permanent representatives: Peter Dossche and Isabel Decrock
Registered-office move6 facts ▸
- Board meeting, 17-06-2023
- Registered-office move, 9800 Deinze,Dhoye 25
- Permanent representative, Peter Dossche
- Permanent representative, Isabel Decrock
- Director in office, PETER DOSSCHE & C° NV (director)
- Director in office, I.Dee BV (director)
06-07
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
29-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
30-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
26-06
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
Gazette deedNBB filing
1 of 4 deeds read
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.